Skip to main navigation Skip to main content

Webinar

Urology:  A 2022 update on prostate cancer detection and incidental renal mass Members login for free access About RACGP online events

Details

Type: Webinar
19 Jul, 7:30 PM - 8:30 PM (AEST)

Contact

For more information:
Email: Samantha Milat
Call: 02 9886 4707

Price

RACGP Members: Free for Members
Non-Members: Free

Free registration

Urology: A 2022 update on prostate cancer detection and incidental renal mass

Webinar 19 Jul, 7:30 PM - 8:30 PM (AEST)

Join Specialists for a Urology update where we will discuss current evidence for prostate cancer detection and diagnosis including PSA, Free PSA, novel markets and genetic markers and will outline the role of multiparametric MRI in investigating suspected prostate cancer and monitoring low risk prostate cancer.

Specialists will also discuss the difference in Simple Cystic versus complex renal cysts and discuss the importance of nephron preservation, particularly in younger patients.

Learning outcomes

  1. Appraise current evidence for prostate cancer detection and diagnosis including PSA, Free PSA, novel markers (such as MiCheck) and genetic markers
  2. Outline the role of multiparametric MRI in investigating suspected prostate cancer and monitoring low risk prostate cancer
  3. Discuss the difference in Simple (Bosniak 1) Cystic versus complex renal cysts (Bosniak 2 to 4)
  4. 2. Discuss the importance of nephron preservation particularly in younger patients
This event attracts 2 CPD points

This event attracts 2 CPD points

Facilitator

Dr Tim Senior
MBBS, FRACGP

Dr Tim Senior is a GP at the Tharawal Aboriginal Corporation in South West Sydney. He is Medical Advisor to the RACGP in Aboriginal and Torres Strait Islander Health and is a clinical senior lecturer in general practice and Indigenous Health at the University of Western Sydney.

Presenters

Professor David Gillatt

Professor Gillatt is a specialist surgeon and Director of Medical Services at Macquarie University Hospital. Professor Gillatt is recognised as one of the world’s foremost robotic surgeons in the treatment of both prostate and bladder cancers. He also has expertise in the discovery and optimisation of biomarkers for early prostate cancer diagnosis and prognosis, and in the effect of ketamine abuse on bladder function. Before joining MQ Health Professor Gillatt was Clinical Director of Urology at Southmead Hospital and Medical Director of the Bristol Urological Institute, where he established the Prostate Cancer Care and Research Centre.

Professor Howard Lau

Professor Howard Lau is a urologist and transplant surgeon trained in Sydney and Oxford. His special interest in urology are renal, adrenal and prostate diseases both benign and malignant. He is very well regarded by his peers for his surgical skill, often invited for lectures and demonstration overseas and in Australia. He has performed a series of firsts in laparoscopic renal surgery since 1998. He has been appointed VMO at Macquarie University Hospital since its beginning. He also practices at Westmead Private Hospital where he is the Chair of the MAC and Head of Urology. He is also the head of Robotic Surgery at Westmead Hospital both the Private and Public, where he heads the surgical team in a series of successful robot assisted renal transplant.

Advertising

© 2022 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807